ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
61 hedge funds and large institutions have $25.8M invested in Zynerba Pharmaceuticals, Inc in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-3
Holders Change %
-4.69%
% of All Funds
1.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
19
Reduced
15
Closed
13
Calls
$742K
Puts
$1.8M
Net Calls
-$1.06M
Net Calls Change
-$1.31M
Top Buyers
| 1 |
Millennium Management
New York
|
$903K |
| 2 |
BlackRock
New York
|
$6.22M |
| 3 |
Group One Trading
Chicago,
Illinois
|
$316K |
| 4 |
Northern Trust
Chicago,
Illinois
|
$1.46M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
$754K |
